BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2847862)

  • 1. A combined glucagonoma and VIPoma syndrome. First pathologic and clinical report.
    Cavallo-Perin P; De Paoli M; Guiso G; Sapino A; Papotti M; Coda R; Pagano G
    Cancer; 1988 Dec; 62(12):2576-9. PubMed ID: 2847862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple hormone secretion by a human pancreatic glucagonoma in culture.
    White A; Tan K; Gray C; Roberts I; Ratcliffe JG
    Regul Pept; 1985 Aug; 11(4):335-45. PubMed ID: 2864720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Watery diarrhea syndrome caused by multihormonal malignant pancreatic islet cell tumor secreting somatostatin, vasoactive intestinal peptide, serotonin, and prostaglandin E--a clinicopathological, biochemical, immunohistochemical, and ultrastructural study.
    Chen YF; Liu TH; Chen SP; Pan GZ; Lu XH; Lu GJ; Zhong SX; Cai LX; Cui QC; Ran QY
    Pancreas; 1986; 1(1):80-9. PubMed ID: 2883647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
    Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
    Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VIPoma syndrome.
    Krejs GJ
    Am J Med; 1987 May; 82(5B):37-48. PubMed ID: 3035922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant metastatic VIPoma in the liver.
    Dohmen K; Fukushima N; Fujisaki T; Iwakiri R; Yamano Y; Nagano M; Wada K; Kodama K; Iwata Y; Hachimine K
    Gastroenterol Jpn; 1991 Aug; 26(4):530-5. PubMed ID: 1655553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
    Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
    J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiodiagnosis of glucagonoma and vipoma, 2 rare endocrine pancreatic tumors].
    de Win JL; Rosenbusch G; Lamers CB; Boetes C; de Boer HH; van Tongeren JH
    Rofo; 1984 May; 140(5):537-44. PubMed ID: 6330802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
    Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
    Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An autopsy case of glucagonoma associated with production of several hormones].
    Fujise K; Matsuura T; Nakagawa J; Egawa K; Hihara M; Nakahara M; Kawase H; Kitahara T; Ohara K; Joh K
    Nihon Naika Gakkai Zasshi; 1988 Jun; 77(6):880-1. PubMed ID: 2906354
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of immunoreactive forms of pancreatic polypeptide in islet cell tumors using antisera with different regional specificities.
    O'Hare MM; Huda I; Sloan JM; Kennedy TL; Buchanan KD
    Cancer; 1985 May; 55(9):1895-8. PubMed ID: 2983868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide producing tumour contains high density of somatostatin receptors.
    Reubi JC; Heitz PU; Gyr K
    Lancet; 1987 Mar; 1(8535):741-2. PubMed ID: 2882148
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of peptide receptors in human endocrine tumours of the pancreas.
    Tang C; Biemond I; Lamers CB
    Gut; 1997 Feb; 40(2):267-71. PubMed ID: 9071943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretin, cholecystokinin, and vasoactive intestinal polypeptide in pancreatic cholera.
    Achord JL
    Ann Intern Med; 1986 Oct; 105(4):632. PubMed ID: 3019205
    [No Abstract]   [Full Text] [Related]  

  • 15. The glucagonoma syndrome.
    Shupack JL; Berczeller PH; Stevens DM
    J Dermatol Surg Oncol; 1978 Mar; 4(3):242-7. PubMed ID: 204668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
    Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
    Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male.
    Abu-Zaid A; Azzam A; Abudan Z; Algouhi A; Almana H; Amin T
    Hematol Oncol Stem Cell Ther; 2014 Sep; 7(3):109-15. PubMed ID: 24785507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A glucagon-secreting alpha-cell carcinoma of the pancreas].
    Matsumoto J; Noto N; Kikuchi Y; Kitazima S; Kaimori M; Sasaki G; Ohto T; Nakamura K
    Nihon Shokakibyo Gakkai Zasshi; 1985 Feb; 82(2):330-4. PubMed ID: 2987580
    [No Abstract]   [Full Text] [Related]  

  • 19. Necrolytic migratory erythema: association with neuroendocrine tumour with predominant insulin secretion.
    Wilkinson SM; Cartwright PH; Allen C; Reeves S; Alexander L; Byrne JP
    Br J Dermatol; 1990 Dec; 123(6):801-5. PubMed ID: 2176092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The glucagonoma syndrome. Review of the literature. Apropos of a case].
    Penchet A; Olivier A; Passa P; Orsoni JL; Charleux H
    J Chir (Paris); 1986 Mar; 123(3):157-63. PubMed ID: 2873145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.